HLA-DRB(L243), 1mg/mL [26628-22-8]
BNUM0458
ApplicationsFunctional Assay, Flow Cytometry, ImmunoPrecipitation, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
Product group Antibodies
ReactivityCanine, Human, Mammals, Monkey, Mouse, Primate
TargetHLA-DRB1
Overview
- SupplierBiotium
- Product NameHLA-DRB(L243), 1mg/mL [26628-22-8]
- Delivery Days Customer9
- ApplicationsFunctional Assay, Flow Cytometry, ImmunoPrecipitation, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
- CAS Number26628-22-8
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDL243
- Concentration1 mg/ml
- Gene ID3123
- Target nameHLA-DRB1
- Target descriptionmajor histocompatibility complex, class II, DR beta 1
- Target synonymsDRB1, HLA-DR1B, HLA-DRB, SS1, major histocompatibility complex, class II, DR beta 1 precursor, HLA class II histocompatibility antigen, DR-1 beta chain, MHC class II HLA-DR beta 1 chain, human leucocyte antigen DRB1, lymphocyte antigen DRB1
- HostMouse
- IsotypeIgG2a
- Protein IDP01911
- Protein NameHLA class II histocompatibility antigen, DRB1 beta chain
- Scientific DescriptionThis MAb reacts with the HLA-DRB1 antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. It binds a conformational epitope on HLA-DR, which depends on the correct folding of the alpha/beta heterodimer. This MAb has been reported to block mixed lymphocyte reactions. The L243 antibody recognizes a different epitope than the LN3 monoclonal antibody, and these antibodies do not cross-block binding to each others respective epitopes. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36kD alpha (heavy) chain and a 28kD beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4 T cells. It is an excellent histiocytic marker in paraffin sections producing intense staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
- SourceAnimal
- ReactivityCanine, Human, Mammals, Monkey, Mouse, Primate
- Storage Instruction-20°C
- UNSPSC41116161



![Whole cell extract (30 μg) was separated by 12% SDS-PAGE, and the membrane was blotted with HLA-DR beta antibody [N1C3] (GTX102047) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.](https://www.genetex.com/upload/website/prouct_img/normal/GTX102047/GTX102047_39995_20240607_WB_24061301_543.webp)